RxDoctor Payments Data

Wei Song, PhD

Anatomic Pathology · San Diego, CANPI 1306164157

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,010 of the $13,108 with a category attached, or 61.1%. Bayer accounts for 62.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $12,158 and has fallen 99.8% since, to $29 in 2024.

$13,108in general payments, 2019–2025

Across 9 payments — averaging $1456.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$8K
  • E.r. Squibb & Sons, L.L.C.$4K
  • AstraZeneca$900
  • Illumina, Inc.$29
$176,717in research payments, 2019–2025

Across 4 payments — averaging $44,179 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$177K

What the payments were for

  • Consulting fees$4,63835%
  • Speaking & faculty fees$8,01061%
  • Travel & lodging$2862%
  • Food & beverage$1751%

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer5$8,156
E.r. Squibb & Sons, L.L.C.2$4,023
AstraZeneca1$900
Illumina, Inc.1$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,108 in reported general payments places this provider in the 85th percentile of 154 anatomic pathology providers in California.

See all anatomic pathology providers in California

Medicare billing

Part B allowed, 2024
$20,284
Medicare patients
327
Services billed
422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →